scispace - formally typeset
Search or ask a question
JournalISSN: 1365-182X

Hpb 

Elsevier BV
About: Hpb is an academic journal published by Elsevier BV. The journal publishes majorly in the area(s): Medicine & Internal medicine. It has an ISSN identifier of 1365-182X. Over the lifetime, 5037 publications have been published receiving 73920 citations. The journal is also known as: Hepato pancreato biliary & Hepato-Pancreato-Biliary.


Papers
More filters
Journal ArticleDOI
01 Jan 2000-Hpb
TL;DR: The purpose of this paper is to present that terminology sought which was anatomically correct, in which anatomical and surgical terms agreed, and which was consistent, self-explanatory, linguistically correct, translatable, precise and concise.
Abstract: Background The Scientific Committee of the IHPBA, meeting in December 1998, created a Terminology Committee to deal with the confusion in nomenclature of hepatic anatomy and liver resections. A terminology was sought which was anatomically correct, in which anatomical and surgical terms agreed, and which was consistent, self-explanatory, linguistically correct, translatable, precise and concise. Discussion After 18 months the International Committee presented a terminology that was accepted by the IHPBA at the recent World Congress in Brisbane. The purpose of this paper is to present that terminology.

1,107 citations

Journal ArticleDOI
01 Apr 2008-Hpb
TL;DR: A review of the literature on the international epidemiological rates of CCA, both intra- and extrahepatic, explores possible explanations for the trends found and the possible role of epidemiological artifact in the findings is discussed.
Abstract: Cholangiocarcinoma (CCA) is a fatal cancer of the biliary epithelium, arising either within the liver (intrahepatic, ICC) or in the extrahepatic bile ducts (extrahepatic ECC). Globally, CCA is the second most common primary hepatic malignancy. Several recent epidemiological studies have shown that the incidence and mortality rates of ICC are increasing. This review of the literature on the international epidemiological rates of CCA, both intra- and extrahepatic, explores possible explanations for the trends found. The possible role of epidemiological artifact in the findings is discussed and the known risk factors for CCA are summarized. These include primary sclerosing cholangitis, liver fluke infestation, congenital fibropolycystic liver, bile duct adenomas, and biliary papillomatosis, hepatolithiasis, chemical carcinogens such as nitrosamines, Thorotrast, chronic viral hepatitis, cirrhosis, chronic non-alcoholic liver disease and obesity. Potential pathways involved in the molecular pathogenesis of CCA are also summarized.

380 citations

Journal ArticleDOI
01 Jul 2011-Hpb
TL;DR: Sarcopenia impacts short- but not long-term outcomes after resection of CRLM, and patients with sarcopenia are at an increased risk of post-operative morbidity and longer hospital stay, but long- term survival is not impacted.
Abstract: Background As indications for liver resection expand, objective measures to assess the risk of peri-operative morbidity are needed. The impact of sarcopenia on patients undergoing liver resection for colorectal liver metastasis (CRLM) was investigated.

356 citations

Journal ArticleDOI
01 Mar 2005-Hpb
TL;DR: In this article, the authors used the serum marker alfa-fetoprotein (AFP) in combination with ultrasonography for the diagnosis of hepatocellular carcinoma (HCC).
Abstract: Hepatocellular carcinoma (HCC) is responsible for a large proportion of cancer deaths worldwide. HCC is frequently diagnosed after the development of clinical deterioration at which time survival is measured in months. Long-term survival requires detection of small tumors, often present in asymptomatic individuals, which may be more amenable to invasive therapeutic options. Surveillance of high-risk individuals for HCC is commonly performed using the serum marker alfa-fetoprotein (AFP) often in combination with ultrasonography. Various other serologic markers are currently being tested to help improve surveillance accuracy. Diagnosis of HCC often requires more sophisticated imaging modalities such as CT scan and MRI, which have multiphasic contrast enhancement capabilities. Serum AFP used alone can be helpful if levels are markedly elevated, which occurs in fewer than half of cases at time of diagnosis. Confirmation by liver biopsy can be performed under circumstances when the diagnosis of HCC remains unclear.

342 citations

Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
2023492
20221,468
2021351
2020262
2019368
2018336